Table 1.
Clinical characteristics and proportions of lymphocyte subsets in peripheral blood of Chinese patients with SLE and healthy controls
| SLE | Controls | |
|---|---|---|
| N | 46 | 28 |
| Age, yr | 34.6 ± 12.7 | 34.8 ± 13.6 |
| Female, n (%) | 42 (91.3) | 25 (89.3) |
| Male, n (%) | 4 (8.7) | 3 (10.7) |
| ANA (+), n (%) | 46 (100) | 0 |
| C3, g/L | 0.76 ± 0.36 | - |
| C4, g/L | 0.16 ± 0.12 | - |
| SLEDAI score | 8.6 ± 4.3 | - |
| WBCs (×109/L) | 5.15 ± 2.91 | 5.88 ± 1.34 |
| Lymphocytes, %a | 15.54 ± 10.93* | 21.26 ± 5.86 |
| CD3+CD4+ T subset, %b | 21.96 ± 9.11* | 30.58 ± 7.75 |
| CD3+CD4- T subset, %b | 26.28 ± 11.81 | 24.27 ± 7.99 |
| Ratio of CD3+CD4+/CD3+CD4- T | 0.97 ± 0.50* | 1.38 ± 0.54 |
Values shown are mean ± SD, unless otherwise noted
ANA, anti-nuclear antibody; C, complement; SLEDAI, systemic lupus erythematosus disease activity index; WBCs, white blood cells
aPercentage of total white blood cells in peripheral blood
bPercentage of total lymphocytes in peripheral blood
*p < 0.05 compared to healthy control group